Works matching IS 15330028 AND DT 2010 AND VI 9 AND IP 5

Results: 9

Safety and Efficacy of Panitumumab Therapy After Progression With Cetuximab: Experience at Two Institutions.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 315, doi. 10.3816/CCC.2010.n.046

By:

Saif, Muhammad Wasif;
Kaley, Kristin;
Chu, Edward;
Copur, M. Sitki

Publication type:

Article

Predictive and Prognostic Biomarkers for Targeted Therapy in Metastatic Colorectal Cancer.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 274, doi. 10.3816/CCC.2010.n.040

By:

Asghar, Uzma;
Hawkes, Eliza;
Cunningham, David

Publication type:

Article

Cetuximab Plus Irinotecan in Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: The LABEL Study.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 282, doi. 10.3816/CCC.2010.n.041

By:

Buzaid, Antonio C.;
de Cerqueira Mathias, Clarissa;
Perazzo, Florencia;
Simon, Sergio D.;
Fein, Luis;
Hidalgo, Jorge;
Murad, Andre M.;
Esser, Regina;
Senger, Stefanie;
Lerzo, Guillermo

Publication type:

Article

Exploratory Study of Hepatic Arterial Infusion Oxaliplatin With Systemic 5-Fluorouracil/Bevacizumab in Patients With Refractory Solid Tumor and Extensive Liver Metastases.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 311, doi. 10.3816/CCC.2010.n.045

By:

Camacho, Luis H.;
Garcia, Sheila;
Panchal, Amar M.;
Lim, JoAnn;
Hong, David S.;
Ng, Chaan;
Madoff, David C.;
Fu, Siqing;
Gayed, Isis;
Kurzrock, Razelle

Publication type:

Article

Targeted Therapies as Adjuvant Treatment for Early-Stage Colorectal Cancer: First Impressions and Clinical Questions.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 269, doi. 10.3816/CCC.2010.n.039

By:

Chibaudel, Benoist;
Tournigand, Christophe;
André, Thierry;
Larsen, Annette K.;
de Gramont, Aimery

Publication type:

Article

Hepatic Arterial Infusion of 5-Fluorouracil for Patients With Liver Metastases From Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter, Retrospective Analysis.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 305, doi. 10.3816/CCC.2010.n.044

By:

Nishiofuku, Hideyuki;
Tanaka, Toshihiro;
Aramaki, Takeshi;
Boku, Narikazu;
Inaba, Yoshitaka;
Sato, Yozo;
Matsuoka, Masaki;
Otsuji, Toshio;
Arai, Yasuaki;
Kichikawa, Kimihiko

Publication type:

Article

Cetuximab is Associated With Excessive Toxicity When Combined With Bevacizumab Plus mFOLFOX6 in Metastatic Colorectal Carcinoma.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 290, doi. 10.3816/CCC.2010.n.042

By:

Ocean, Allyson J.;
Polite, Blase;
Christos, Paul;
Horvath, Lisa;
Hamilton, Anne;
Matulich, Daniel;
Chen, Helen X.;
Sparano, Joseph A.;
Kindler, Hedy L.

Publication type:

Article

Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 297, doi. 10.3816/CCC.2010.n.043

By:

Messersmith, Wells A.;
Jimeno, Antonio;
Jacene, Heather;
Zhao, Ming;
Kulesza, Piotr;
Laheru, Daniel A.;
Kahn, Yasmin;
Spira, Alexander;
Dancey, Janet;
Iacobuzio-Donahue, Christine;
Donehower, Ross C.;
Carducci, Michael;
Rudek, Michelle A.;
Hidalgo, Manuel

Publication type:

Article

CLINICAL Colorectal Cancer.

Published in:

Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 264

By:

CIG Media Group

Publication type:

Article